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Abstract L-Arginine plays an essential role in the energetic
metabolism of Trypanosoma cruzi. In this work we propose a
relationship between L-arginine uptake, arginine kinase activity
and the parasite replication ability. In epimastigote cultures
L-arginine uptake decreases continuously accompanying a cell
replication rate reduction. The use of conditioned or fresh me-
dium mimics uptake variations. Interestingly, in non-replicative
trypomastigote cells, L-arginine uptake was undetectable. The
association between L-arginine uptake and cell replication was
demonstrated using the antimitotic agent hydroxyurea. Arginine
kinase, the enzyme responsible for phosphoarginine and ATP
synthesis, also shows a di¡erential activity in epimastigote and
trypomastigote parasite stages. " 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Knowledge of the intake and metabolism of medium com-
ponents by parasites is essential for the design and improve-
ment of anti-parasitic drugs. Intake mechanisms include
passive di¡usion, endocytosis, receptor-mediated uptake or
transporter-mediated uptake [1].
Arginine is a key substrate for several metabolic pathways.
Moreover, in Trypanosoma cruzi, the £agellated protozoan
causing Chagas’ disease, this amino acid is essential for in
vitro cultivation of epimastigote cells [2].
A high-a⁄nity, very speci¢c L-arginine transport has been
characterized in T. cruzi. In epimastigotes, this process under-
goes saturation and is dependent on L-arginine concentration.
Among several amino acids and their derivatives, only L-ho-
moarginine, D-arginine, L-canavanine, L-ornithine and L-citrul-
line elicited a weak inhibition of the L-arginine transport.
After uptake, the major product detected was characterized
as phosphoarginine [3]. Phosphoarginine plays a critical role
as an energy reserve, since the high-energy phosphate is easily
transferred to ADP when ATP is needed. It has been pro-
posed that phosphoarginine supports bursts of cellular activ-
ity before metabolic events such as glycogenolysis, glycolysis
and oxidative phosphorylation are switched on [4^6]. Arginine
kinase is a key enzyme of the energetic metabolism, described
for the ¢rst time in T. cruzi by our laboratory [7]. Epimasti-
gote growth rate and arginine kinase speci¢c activity have
been correlated. Enzyme amounts and speci¢c activity in-
creased continuously during exponential growth, reaching
maximum values at the stationary phase of growth. Therefore,
arginine kinase was proposed as a regulator of energetic re-
serves under starvation stress conditions [8]. Herein, we de-
scribe several ways to regulate L-arginine uptake such as me-
dium composition, cell density, replication rate and L-arginine
starvation. In addition, a relationship between arginine kinase
speci¢c activity, substrate transport and T. cruzi stages is pro-
posed.
2. Materials and methods
2.1. Reagents
Reagents were from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Parasite cultures and cell extracts
Epimastigote cells of the CL Brener strain were cultured at 28‡C in
plastic £asks (25 cm2), containing 5 ml of LIT medium (started with
106 cells/ml) supplemented with 10% heat-inactivated fetal calf serum
(FCS), 100 U/ml penicillin, and 100 Wg/ml streptomycin [9]. At the
indicated times, cells from three independent culture £asks were
counted using a hemocytometric chamber.
Trypomastigote cells (CL Brener strain) were obtained as previ-
ously described [10]. LLC-MK2 cell monolayers were grown in Dul-
becco’s modi¢ed Eagle’s medium (DMEM) supplemented with 5%
FCS at 37‡C. During infection, the FCS concentration was reduced
to 2%. The trypomastigotes, released from the LLC-MK2 cultures
around day 5^6 after inoculation, were washed three times in
DMEM before being used for further experiments. Each LLC-MK2
culture £ask was used for a single trypomastigote infection. Aliquots
(0.1^2 ml) were harvested by centrifugation at 1500Ug for 10 min and
washed three times with phosphate-bu¡ered saline (PBS). Trypomas-
tigotes were counted using a hemocytometric chamber and viability
was assessed by direct microscopic examination.
Epimastigote or trypomastigote cell pellets were then resuspended
in 50 mM HEPES bu¡er, pH 7.3, containing 0.01 mg/ml leupeptin,
25 U/ml aprotinin and 0.5 mM phenylmethylsulfonyl £uoride, and
lysed by six cycles of freezing in liquid N2 and thawing at 4‡C. The
extracts were then centrifuged at 10 000Ug for 10 min.
2.3. Uptake assays
Aliquots of epimastigote or trypomastigote cell cultures (3U107
parasites), grown for the mentioned periods of time, were centrifuged
at 8000Ug for 30 s, and washed once with PBS. Cells were then
resuspended in 1 ml of PBS, preincubated 2 h at 30‡C to deplete
the endogenous L-arginine pool [11,12], and then centrifuged at
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8000Ug for 30 s. Cells were then again resuspended in 1 ml of PBS
containing 25 WM L-[2,3-3H]arginine (NEN/DuPont, Boston, MA,
USA; 0.5 WCi). Following incubation for 10 min at 30‡C, cells were
centrifuged as indicated above, and washed with 1 ml of ice-cold PBS.
Pellets were then resuspended in 1 ml of water and counted for radio-
activity in UltimaGold XR liquid scintillation cocktail (Packard In-
strument Co., Meriden, CT, USA). Non-speci¢c uptake and carry-
over were measured in uptake mixtures containing 100 mM L-arginine
[3]. Assays were run at least in triplicate. Cell viability was assessed by
direct microscopic examination.
2.4. Arginine kinase assay
The incubation mixture contained 25 mM HEPES bu¡er, pH 7.3,
2 mM ATP, 5 mM MgCl2, 10 mM 2-mercaptoethanol, 1 mM L-[2,3-
3H]arginine (NEN Life Science Products, Boston, MA, USA; 0.5 WCi
per assay), and the enzyme source (8 Wg of protein), in a total volume
of 0.2 ml. Incubations were carried out 10 min at 30‡C. Reactions
were stopped by the addition of 1 ml of 25 mM HEPES bu¡er, pH
7.3, containing 10 mM L-arginine and 5 mM EDTA (stop bu¡er). The
mixtures were then resolved by passage through a strong anion ex-
change resin, Dowex AG 1-X4, 200^400 mesh, chloride form (1 ml,
Bio-Rad Laboratories, Hercules, CA, USA) mounted into tulip col-
umns and equilibrated with stop bu¡er. After loading the samples, the
columns were washed with 3 ml of 25 mM HEPES bu¡er, pH 7.3, and
eluted with 2 ml of 1 M NaCl, 0.1 N HCl [7]. Results are the average
of triplicate assays. The authenticity of phosphoarginine as reaction
product was validated by procedures described elsewhere [7].
2.5. Western blot analysis
SDS^PAGE of protein samples was carried out as described by
Laemmli [13]. Polypeptides were electrotransferred from polyacryl-
amide gels to Hybond-C membranes (Amersham Pharmacia Biotech,
Piscataway, NJ, USA). For antibody reaction, the transferred mem-
branes were blocked with a 5% (w/v) non-fat milk suspension for 2 h,
after incubation for 2 h with a 1:1000 dilution of the mouse poly-
clonal anti-arginine kinase antiserum obtained previously in our lab-
oratory [7]. Detection was carried out by incubating with a 1:2000
dilution of sheep anti-mouse IgG conjugated with horseradish peroxi-
dase (Amersham Pharmacia Biotech). The latter was developed with
the Renaissance Western blot Chemiluminescence Reagent Plus (NEN
Life Science Products).
2.6. Hydroxyurea treatment
Hydroxyurea acts as an inhibitor of ribonucleotide reductase. Con-
sequently, DNA replication is inhibited and parasite replication is
arrested. Hydroxyurea has been used to arrest the cell cycle of a
wide variety of cells from the lower eukaryote order Kinetoplastida,
including T. cruzi [14]. T. cruzi epimastigote cells (106 cells/ml) were
grown in LIT medium for 2 days. A ¢ltered hydroxyurea solution was
added to the cell cultures to a ¢nal concentration of 20 mM. After
24 h of treatment cells were washed twice in PBS and resuspended in
conditioned medium from control cells (without treatment) corre-
sponding to the same day of culture for 24 h [14]. Cell viability was
assessed by direct microscopic examination.
2.7. Analytical methods
Protein was determined according to Bradford [15].
3. Results
3.1. Arginine uptake during epimastigote growth
During the interval between the 3rd (d3) and 15th day (d15)
of epimastigote cell cultures, L-arginine uptake decreased con-
tinuously from 30.85 pmol/min/107 cells ( S 0.62) on d3 to 1.47
pmol/min/107 cells ( S 0.13) on d15 (approximately 21-fold).
Fig. 1A shows the inverse correlation between L-arginine
uptake and cell density, the latter increasing approximately
12.5-fold in the same period of time while the replication
rate decreased from 1.93 to 0.43 cell duplications per day
(Fig. 1B).
In order to check whether medium components might in-
£uence L-arginine uptake, epimastigote cell cultures from d3
were incubated for 16 h in conditioned medium obtained from
15-day grown parasites (d15 medium) or cells from d15 were
incubated in fresh medium. A 9.7-fold increase in the L-argi-
nine uptake was observed when d15 parasites were treated
with fresh medium, and a 5.8-fold decrease was observed
when d3 parasites were treated with conditioned medium
from d15 parasites (Table 1).
To test the kinetics of the increase in L-arginine uptake, d15
parasites were assayed after a fresh medium treatment for
2, 4, 8, and 16 h. L-Arginine uptake increased by a rate of
Fig. 1. T. cruzi L-arginine uptake as a function of cell growth.
A: Cell densities (b) and L-arginine uptake (E) in epimastigotes
growing between d3 and d15. B: Cell replication rate (number of
cell divisions per day), calculated as the average at 3-day intervals.
Table 1
L-Arginine uptake under di¡erent culture conditions
Condition Vmax (pmol/min/1037 cells) S.D. ( S )
(a) d3 30.85 0.62
(b) d3+CM 5.32* 0.14
(c) d3 w/o starv 9.07* 0.21
(d) d15 1.47 0.13
(e) d15+FM 14.26* 0.22
(f) d15 w/o starv 0.86* 0.06
D3 (and d15 epimastigote cells were assayed for arginine. Control
cells without treatment (a and d); d3 cells treated with conditioned
medium (CM, b); d3 and d15 cells without starvation (w/o starv,
c and f) and d15 cells treated with fresh medium (FM, e).
*P6 0.05, signi¢cantly di¡erent in t-test. Treated cultures (d3+CM,
d3 w/o starv, d15+FM and d15 w/o starv) were compared with the
untreated controls (d3 and d15 respectively).
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1.33 pmol/min/107 cells per hour for the ¢rst 8 h and 0.27
pmol/min/107 cells per hour in the subsequent 8 h.
3.2. In£uence of the culture medium conditions and L-arginine
starvation on the L-arginine uptake
Modi¢ed LIT media were prepared omitting one or more
components and then parasites from d15 were treated with the
di¡erent fresh media for 16 h. All the treatments signi¢cantly
increased the L-arginine uptake similarly to complete LIT me-
dium, except the media without a carbon source, including
tryptose, liver extract, glucose or serum in an additive man-
ner. The number of parasites was normalized in all treatments
(data not shown).
In T. cruzi, the absence of L-arginine in the pre-incubation
medium (PBS or PBS plus 11 mM glucose) increased the
uptake rate of d3 parasites 3.4-fold with 3 h of pre-incubation
time. When cells were pre-incubated with 10 mM unlabeled
L-arginine, washed to eliminate the amino acid, and then sub-
jected to a standard uptake assay, the increase in the uptake
rate was abolished. No e¡ects were observed when L-arginine
was replaced by other amino acids (data not shown). When
parasites from d15 were subjected to starvation for 3 h the
increment was 1.7-fold (Table 1). 3.3. Relationship between the L-arginine uptake and arginine
kinase activity along the parasite growth curve and life
cycle
Previous reports from our group describe the increase in
arginine kinase expression and activity along the parasite
growth phases [8]. These data suggest a relationship between
arginine kinase activity and L-arginine uptake with the cell
replication capacity. In order to test the latter hypothesis,
these processes were investigated in trypomastigotes, the
non-replicative stage of T. cruzi. Arginine kinase activity
from cell culture-derived trypomastigotes was 2.5-fold higher
(0.3 nmol/min/mg protein) than that from d7 epimastigotes
(0.12 nmol/min/mg protein). These results were con¢rmed by
Western blot analysis of the expressed enzyme (Fig. 2A,B).
L-Arginine uptake was at least 30-fold lower in trypomasti-
gotes than in d7 epimastigotes (Fig. 2A). It is worth mention-
ing that LIT cultured cells were at least 95% epimastigote
stage.
3.4. E¡ect of cell division arrest on L-arginine uptake
Epimastigote cells from d2 were treated with the antimitotic
hydroxyurea (20 mM) in LIT medium. After 24 h of treat-
ment, the cell replication rate decreased from 1.02 (control) to
0.11 (hydroxyurea) duplications per day and the L-arginine
uptake decreased by 40% with respect to the control values
(Fig. 3). When cells were washed and reinoculated into a
conditioned medium from control cells (d3) for 24 h, the hy-
droxyurea-treated group recovered 100% of the L-arginine up-
take and the replication rate reached 0.8 cell duplications per
day (Fig. 3). No hydroxyurea-mediated toxicity was observed
during the 24-h exposure.
4. Discussion
Nutritional conditions during the T. cruzi life cycle impose
a restriction to energy availability. The parasites are exposed
to a wide range of conditions during their complex life cycle.
In the mammalian host the trypomastigote and amastigote
cellular stages bene¢t from a rather constant environment,
including a steady supply of glucose and amino acids. In
Fig. 2. Arginine kinase activity and expression, and L-arginine up-
take in epimastigote and trypomastigote cells. A: Epimastigote
(EM) and trypomastigote (TM) cells were assayed for arginine ki-
nase activity (AK) (10 Wg of soluble extracts) and L-arginine uptake
(AU). The results were expressed as percentage of the epimastigote
corresponding values. B: Western blot analysis. SDS^PAGE of pro-
tein samples (30 Wg) from trypomastigote (T) and d7 epimastigote
(E) cells were transferred to a Hybond C membrane and incubated
with a mouse polyclonal arginine kinase antiserum. Arrow indicates
the band corresponding to arginine kinase (40 kDa).
Fig. 3. E¡ect of hydroxyurea treatment on L-arginine uptake. Epi-
mastigote cells were grown for 2 days in LIT medium. One culture
was treated with the antimitotic hydroxyurea (arrow). The graph
represents the parasite density of the hydroxyurea-treated culture
(b) or the control culture (E). The inset shows the L-arginine uptake
by the control (black columns) or by the hydroxyurea-treated cul-
ture (gray columns).
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contrast, feeding status determines variations in the availabil-
ity of nutrients for the epimastigote stage in the insect vector
[16]. These data reinforce the importance of understanding the
T. cruzi adaptive changes in nutrient transport processes and
energetic metabolism.
In this work we report a continuous decrease in the L-argi-
nine uptake accompanying the reduction in parasite repli-
cation rates, together with an increase in cell density and
consequent nutrient depletion of the medium. Furthermore,
L-arginine uptake shows a negative correlation with the pre-
viously described increase in the arginine kinase expression
and activity [8]. Treating the cells with conditioned medium
or fresh medium mimics L-arginine uptake variations. In ad-
dition, omission of any carbon source in LIT medium in-
creases the L-arginine uptake at a lower rate when compared
to the complete medium, and decreases parasite replication. It
is postulated that changes in medium conditions and/or the
appearance of a density-derived factor that a¡ects cell repli-
cation ability, modulate L-arginine uptake.
Previous works report substrate-regulated arginine trans-
porters, such as mammalian CAT-1 and CAT-2 [17^19], and
this e¡ect is termed adaptive regulation. Accordingly, L-argi-
nine uptake was herein reported to increase with L-arginine
starvation.
L-Arginine uptake and arginine kinase activity were also
investigated in the non-replicative form, trypomastigote. The
absence of L-arginine uptake and the higher rate of arginine
kinase activity observed in trypomastigotes, when compared
to the replicative cellular stage epimastigote, led us to postu-
late a correlation between cell replication and arginine metab-
olism. In addition, the results obtained with the cells treated
with the antimitotic hydroxyurea support this hypothesis.
In trypanosomatids, amino acids can be used as a carbon
source, in particular, insect stages grow even better on amino
acids than glucose. In addition, 98^99% of the total carbon
consumption is used in the replication process [20]. In vivo,
the epimastigote cell replication rate is dramatically altered
depending on the nutritional state of the insect vector [16].
Taking these data into account, it can be postulated that
under nutritional stress conditions, the cell replication rate
decreases and the parasites can use phosphoarginine reserves
in order to synthesize ATP whereas the produced free arginine
can be used as a carbon source. The replication-associated
decrease in the arginine £ux facilitates the arginine kinase
reaction in the ATP synthesis direction.
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